Source:http://linkedlifedata.com/resource/pubmed/id/12145290
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
39
|
pubmed:dateCreated |
2002-9-23
|
pubmed:abstractText |
Hypertension is a serious health problem in Western society, in particular for the African-American population. Although previous studies have suggested that the angiotensinogen (AGT) gene locus is involved in human essential hypertension, the molecular mechanisms involved in hypertension in African-Americans remain unknown. We show that an A/G polymorphism at -217 in the promoter of the AGT gene plays a significant role in hypertension in African-Americans. The frequency of the -217A allele was increased significantly in African-American hypertensive subjects compared with normotensive controls. We also show that the nucleotide sequence of this region of the AGT gene promoter bound strongly to CAAT/enhancer-binding protein (C/EBP) family transcription factors when nucleoside A was present at -217. In addition, we show that reporter constructs containing the human AGT gene promoter with nucleoside A at -217 had increased basal transcriptional activity upon transient transfection in HepG2 cells compared with reporter constructs with nucleoside G at -217. Finally, we show that interleukin-6 treatment in the presence or absence of overexpressed C/EBPbeta increased the promoter activities of reporter constructs containing nucleoside A at -217 compared with reporter constructs containing nucleoside G at -217. Because the AGT gene is expressed primarily in liver and adipose tissue, and C/EBP family transcription factors play an important role in gene expression in these tissues, we propose that increased transcriptional activity of the -217A allele of the human AGT gene is associated with hypertension in African-Americans.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0021-9258
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
27
|
pubmed:volume |
277
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
36889-96
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:12145290-Adult,
pubmed-meshheading:12145290-African Continental Ancestry Group,
pubmed-meshheading:12145290-Aged,
pubmed-meshheading:12145290-Angiotensinogen,
pubmed-meshheading:12145290-Cell Line,
pubmed-meshheading:12145290-Female,
pubmed-meshheading:12145290-Genes, Reporter,
pubmed-meshheading:12145290-Humans,
pubmed-meshheading:12145290-Hypertension,
pubmed-meshheading:12145290-Male,
pubmed-meshheading:12145290-Middle Aged,
pubmed-meshheading:12145290-Oligonucleotides,
pubmed-meshheading:12145290-Plasmids,
pubmed-meshheading:12145290-Polymorphism, Genetic,
pubmed-meshheading:12145290-Promoter Regions, Genetic,
pubmed-meshheading:12145290-Protein Binding,
pubmed-meshheading:12145290-Transfection,
pubmed-meshheading:12145290-United States
|
pubmed:year |
2002
|
pubmed:articleTitle |
Angiotensinogen gene polymorphism at -217 affects basal promoter activity and is associated with hypertension in African-Americans.
|
pubmed:affiliation |
Department of Pathology, New York Medical College, Valhalla, New York 10595, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|